Expertise

Sowbhagya Suresh

Consultant

Expertise:

Commercialization, Consulting (Strategy Management & Regulatory), Market Access, Market Research, Rare Disease

Sowbhagya is an Associate Consultant at EVERSANA APAC. She has more than 2 years of experience in healthcare. She has worked with several MNC clients on market entry assessments, valuation of assets in rare indications, deal negotiation strategies and opportunity assessment engagements across G7 and APAC countries.

Prior to joining EVERSANA she has worked with Decision Resources Group and MetFlux Research, an early stage biotech startup. She holds a B.Tech from National Institute of Technology(NIT), Karnataka and majored in Chemical Engineering.

Articles by Sowbhagya Suresh

Learning How to Play Dilution Dodgeball

The healthcare industry is reaching new heights in innovation, and as new drugs are founded, owners of biotech companies must decide whether or not they want to independently bring their product to market.  Developing and successfully commercializing a biopharma product is no small undertaking. The multi-year journey is fraught with clinical, financial and operational uncertainties that many companies fail […]

Escaping the Chronic Microcap Trap: How Launching Alone Is the Only Option for Growth

As C-suite leaders in pharma wrestle with the pros and cons of launching alone, licensing or partnering with another company to launch their product, one factor they must consider is the impact their decision will have on their current and future market valuation. The question is this: How much of a premium does the market […]

The Chronic Microcap Trap: How Launch Is The Escape for True Growth

Pre-commercial pharma companies face a common choice: commercialize products independently or collaborate with another pharmaceutical company as a commercialization partner. As the C-suite leaders in these organizations wrestle with the pros and cons of this choice, one factor they must consider is the impact their decision will have on their current and future market valuation. […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.